\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tThe National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 39 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013.<\/p>\n
The formulations cover a wide range of medicines, including those used to treat hypertension, diabetes, HIV, heart disease and eye infections, with the aim of making them more affordable for patients.<\/p>\n
The notification was issued on July 8. It is a retail price fixation order for new drug formulations under the DPCO, 2013, and not a price reduction order.<\/p>\n
Among the medicines included, Amlodipine + Bisoprolol + Telmisartan Tablets, used for the treatment of hypertension (high blood pressure), have been fixed at Rs 14.74 per tablet.<\/p>\n
The retail price of Nepafenac + Moxifloxacin Ophthalmic Solution, an eye drop used after eye surgery and for the treatment of bacterial eye infections, has been fixed at Rs 68.64 per ml.<\/p>\n
Similarly, Clopidogrel + Aspirin + Atorvastatin Capsules, which are used to reduce the risk of heart attack and stroke, have been priced at Rs 6.37 per capsule.<\/p>\n
The NPPA also reiterated that retailers and dealers are required to prominently display the price lists provided by manufacturers. — ANI\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n","protected":false},"excerpt":{"rendered":"The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 39 new drug formulations under the…\n","protected":false},"author":2,"featured_media":1082670,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4315],"tags":[1500,4829,105,10816,466,284344,17128,4326,60161,284343,16,15],"class_list":["post-1082669","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-breaking-news","tag-columns","tag-health","tag-india-news","tag-interviews","tag-live-commentary","tag-live-updates","tag-medication","tag-news-india","tag-rediff","tag-uk","tag-united-kingdom"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/116901335808330514","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1082669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=1082669"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1082669\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/1082670"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=1082669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=1082669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=1082669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}